Vioxx, Rofecoxib News

It hasn't been that long since the arthritis drug Vioxx was taken off the market for increased risk of stroke and heart attack in some patients.

A decade ago, the U.S. Food and Drug Administration approved use of rofecoxib, a nonsteroidal anti-inflammatory drug that went on to become a hugely popular pain-relief medication under the brand name Vioxx.

WASHINGTON Despite a recommendation for restructuring three years ago following a prescription painkiller scandal, the Food and Drug Administration still hasna t made the changes, according to published reports.

The Vioxx scandal, and the Food & Drug Administrationa s role in it, has not brought about much change at the agency, according to a new government report.

The U.S. Supreme Court has agreed to decide whether Australian investors can use U.S. securities law and American courts to sue an Australia-based bank for fraud.

Editor's Choice Main Category: Clinical Trials / Drug Trials Also Included In: Pharma Industry / Biotech Industry Article Date: 30 Nov 2009 - 0:00 PST Two experts question on bmj.com today whether the conflict of interest is unethical when drug companies perform clinical trials on their own medicines.

Lawyers for Merck & Co. have told the Supreme Court that investors waited too long to sue over its warnings about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market.

A new study suggests that evidence linking heart risks to Vioxx, the Merck arthritis drug pulled from the market in 2004, was apparent in 2000, Health Day reports .

ScienceDaily a ' Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug , could have been identified nearly four years before its manufacturer, Merck & Co.

Main Category: Cardiovascular / Cardiology Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug , could have been identified nearly four years before its manufacturer, Merck & Co.

Merck's Vioxx Scandal Widens: Drug Maker Knew Vioxx Was Deadly for Years Before Risk Was Made Public >> Posted By onlyonesecret 11 hours, 40 minutes ago in Health & Fitness The Vioxx scandal widened this week as new research published in the Archives of Internal Medicine reveals that Vioxx maker Merck held data for three years that proved Vioxx ...

Merck & Co. is disputing it knew Vioxx significantly increased the risk of heart attacks at least three years before it was pulled off the market.

Washington, Nov 24 : A new American report suggests that clinical trial data had pointed out the association between the anti-inflammatory drug rofecoxib and cardiovascular risk nearly eight years ago.

It's been 5 years since the then CEO of giant drug-maker Merck, Raymond Gilmartin, testified to the US Senate Finance Committee regarding evidence showing that Vioxx increases the risk of death due to heart attacks, strokes and other cardiovascular events.

The significant cardiovascular risks linked to Vioxx could have been identified nearly four years before the anti-inflammatory medication was taken off the market, a new study has concluded, but consumers and physicians didn't have access to such information at the time.

Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine .

Washington and Lee University School of Law Prof. Lyman Johnson filed in October an amicus brief with the U.S. Supreme Court in the case Merck & Co.

Federal health regulators have found tiny particles of trash in drugs made by biotechnology firm Genzyme.

The Obama administration sided with investors Monday in a U.S. Supreme Court case that examines whether shareholders of Merck & Co.

When Richard Clark was named CEO and president of Merck in 2005, the drug behemoth was reeling in the wake of the Vioxx scandal, which in 2004 forced the company to withdraw the blockbuster painkiller for safety reasons.